Concepedia

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

Unknown author(s)

The Lancet Infectious Diseases · 2022 · 62 citations · 23 references

Open access

References

23

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine · 2020 · 10.7K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Two-sided confidence intervals for the single proportion: comparison of seven methods

Robert G. Newcombe · Statistics in Medicine · 1998 · 5.1K citations

Public Health, Biostatistics, Mathematics +16

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14